Table 4.
Pairwise multiple comparisons of Annexin V assay
| Reference group | Comparison group | Statistical significance after(P) | ||
|---|---|---|---|---|
|
| ||||
| 1days | 3days | 7day | ||
| CEM | CEM | - | 0.4a,* | <0.0001b,* |
| SIM 1 | <0.0001* | <0.0001* | <0.0001* | |
| SIM 0.1 | 0.3 | <0.9 | 0.3 | |
| SIM 0.01 | <0.0001* | <0.0001* | <0.0001* | |
| CEM/SIM 1 | 0.1 | 0.0003* | <0.0001* | |
| CEM/SIM 0.1 | <0.0001* | <0.0001* | <0.0001* | |
| CEM/SIM 0.01 | <0.0001* | <0.0001* | <0.0001* | |
| MTA | <0.0001* | <0.0001* | <0.0001* | |
| Control- | <0.0001* | <0.0001* | <0.0001* | |
| SIM 1 | SIM 1 | - | 0.004a,* | <0.0001b,* |
| SIM 0.1 | <0.0001* | <0.0001* | <0.0001* | |
| SIM 0.01 | <0.0001* | <0.0001* | <0.0001* | |
| CEM/SIM 1 | <0.0001* | <0.0001* | <0.0001* | |
| CEM/SIM 0.1 | <0.0001* | <0.0001* | <0.0001* | |
| CEM/SIM 0.01 | <0.0001* | <0.0001* | <0.0001* | |
| MTA | <0.0001* | <0.0001* | <0.0001* | |
| Control- | <0.0001* | <0.0001* | <0.0001* | |
| SIM 0.1 | SIM 0.1 | - | <0.0001a,* | 0.002b |
| SIM 0.01 | 0.003* | <0.0001* | <0.0001* | |
| CEM/SIM 1 | <0.9 | <0.0001* | <0.0001* | |
| CEM/SIM 0.1 | 0.05 | <0.0001* | <0.0001* | |
| CEM/SIM 0.01 | <0.0001* | <0.0001* | <0.0001* | |
| MTA | <0.0001* | <0.0001* | <0.0001* | |
| Control- | <0.0001* | <0.0001* | <0.0001* | |
| SIM 0.01 | SIM 0.01 | - | 0.8a | 0.07b |
| CEM/SIM 1 | 0.01* | 0.5 | 0.2 | |
| CEM/SIM 0.1 | <0.9 | <0.9 | <0.9 | |
| CEM/SIM 0.01 | <0.9 | <0.9 | 0.03 | |
| MTA | 0.9 | 0.3 | <0.0001* | |
| Control- | 0.01* | <0.0001* | <0.0001* | |
| CEM/SIM 1 | CEM/SIM 1 | - | <0.9a | 0.01b |
| CEM/SIM 0.1 | 0.1 | 0.3 | 0.2 | |
| CEM/SIM 0.01 | <0.0001* | <0.05 | <0.0001* | |
| MTA | 0.0003* | 0.0003* | <0.0001* | |
| Control- | <0.0001* | <0.0001* | <0.0001* | |
| CEM/SIM 0.1 | CEM/SIM 0.1 | - | <0.9a | 0.1b |
| CEM/SIM 0.01 | 0.4 | <0.9 | 0.02* | |
| MTA | 0.7 | 0.1 | <0.0001* | |
| Control- | 0.001* | <0.0001* | <0.0001* | |
| CEM/SIM 0.01 | CEM/SIM 0.01 | - | 0.3a | <0.9b |
| MTA | <0.9 | <0.9 | 0.7 | |
| Control- | 0.7 | 0.002* | 0.0006* | |
| MTA | MTA | - | <0.9a | <0.9b |
| Control- | 0.3 | 0.2 | 0.3 | |
a Comparison between day 3 and 1, b Comparison between day 7 and 3, *Statistically significant, Green: Numerical superiority of the reference group, Red: Numerical superiority of the comparison group, CEM: Bioceramic cement with full concentration, SIM 1: Simvastatin with concentration of 1 μM, SIM 0.1: Simvastatin with concentration of 0.1 μM, SIM 0.01: Simvastatin with concentration of 0.01 μM, CEM/SIM 1: Bioceramic cement containing simvastatin 1 μM, CEM/SIM 0.1: Bioceramic cement containing simvastatin 0.1 μM, CEM/SIM 0.01: Bioceramic cement containing simvastatin 0.01 μM, MTA: Mineral trioxide aggregate